Last reviewed · How we verify

NCT04920994

Modified Thoracoabdominal Nerve Block Through Perichondrial Approach (M-TAPA) in Major Abdominal Surgeries

Completed NA Last updated 11 July 2022
What this trial tests

NA trial testing M-TAPA block in Abdominal Surgery in 80 participants. Completed in 1 July 2022.

Timeline
13 August 2021
Primary endpoint
1 July 2022
1 July 2022

Quick facts

Lead sponsorSameh Fathy
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment80
Start date13 August 2021
Primary completion1 July 2022
Estimated completion1 July 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Sameh Fathy — full company profile →

Who can join

Adults 18 to 65, any sex, with Abdominal Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be conducted to evaluate efficacy of ultrasound guided modified thoracoabdominal nerves block via a new perichondrial approach (M-TAPA) for postoperative analgesia in major abdominal surgeries in comparison to subcostal transverse abdominis plane (SCTAP) block. It is hypothesized that M-TAPA block will be advantageous to SCTAP block as a promising effective alternative for analgesia for major abdominal surgeries with fewer side effects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of M-TAPA block

Trials testing the same drug.

Other recruiting trials for Abdominal Surgery

Currently open trials in the same condition.

Other Sameh Fathy trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04920994.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing